|
1
|
Pastuszak Z, Tomczykiewicz K,
Piusinska-Macoch R, Stępień A and Kordowska J: The occurrence of
tumors of the central nervous system in a clinical observation. Pol
Merkur Lekarski. 38:88–92. 2015.PubMed/NCBI
|
|
2
|
Ho VK, Reijneveld JC, Enting RH, Bienfait
HP, Robe P, Baumert BG and Visser O; Dutch Society for
Neuro-Oncology (LWNO), : Changing incidence and improved survival
of gliomas. Eur J Cancer. 50:2309–2318. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Malzkorn B and Reifenberger G: Practical
implications of integrated glioma classification according to the
World Health Organization classification of tumors of the central
nervous system 2016. Curr Opin Oncol. 28:494–501. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Olar A and Aldape KD: Using the molecular
classification of glioblastoma to inform personalized treatment. J
Pathol. 232:165–177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang L, Liu J, Yu X, Shi L, Liu J, Xiao H
and Huang Y: Drug-drug interactions between moxifloxacin and
rifampicin based on pharmacokinetics in vivo in rats. Biomed
Chromatogr. 30:1591–1598. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Panditharatna E, Yaeger K, Kilburn LB,
Packer R and Nazarian J: Clinicopathology of diffuse intrinsic
pontine glioma and its redefined genomic and epigenomic landscape.
Cancer Genet. 208:367–373. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stoltz K, Sinyuk M, Hale JS, Wu Q, Otvos
B, Walker K, Vasanji A, Rich JN, Hjelmeland AB and Lathia JD:
Development of a Sox2 reporter system modeling cellular
heterogeneity in glioma. Neuro Oncol. 17:361–371. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang H, Song X, Huang Q, Xu T, Yun D, Wang
Y, Hu L, Yan Y, Chen H, Lu D and Chen J: LGALS3 promotes treatment
resistance in glioblastoma and is associated with tumor risk and
prognosis. Cancer Epidemiol Biomarkers Prev. 28:760–769. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang L, Zhu Y, Cheng H, Zhang J, Zhu Y,
Chen H, Chen L, Qi H, Ren G, Tanget J, et al: The increased
expression of estrogen related receptor α correlates with wnt5a and
poor prognosis in patients with glioma. Mol Cancer Ther.
152018.(18): 173–184, 2019.
|
|
10
|
Wang WT and Chen YQ: Circulating miRNAs in
cancer: From detection to therapy. J Hematol Oncol. 7:862014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Harrandah AM, Mora RA and Chan EKL:
Emerging microRNAs in cancer diagnosis, progression, and immune
surveillance. Cancer Lett. 438:126–132. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen L, Hu J, Pan L, Yin X, Wang Q and
Chen H: Diagnostic and prognostic value of serum miR-99a expression
in oral squamous cell carcinoma. Cancer Biomark. 23:333–339. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng YH, Deng ZH, Hao H, Wu XL, Gao H,
Tang SH and Tang H: MicroRNA-23a promotes colorectal cancer cell
survival by targeting PDK4. Exp Cell Res. 373:171–179. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gao W, Hong Z, Huang H, Zhu A, Lin S,
Cheng C, Zhang X, Zou G and Shi Z: miR-27a in serum acts as
biomarker for prostate cancer detection and promotes cell
proliferation by targeting Sprouty2. Oncol Lett. 16:5291–5298.
2018.PubMed/NCBI
|
|
15
|
Xiang J, Wu Y, Li DS, Wang ZY, Shen Q, Sun
TQ, Guan Q and Wang YJ: miR-584 suppresses invasion and cell
migration of thyroid carcinoma by regulating the target oncogene
ROCK1. Oncol Res Treat. 38:436–440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kong Q, Han J, Deng H, Wu F, Guo S and Ye
Z: miR-431-5p alters the epithelial-to-mesenchymal transition
markers by targeting UROC28 in hepatoma cells. Onco Targets Ther.
11:6489–6503. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin W, Nie Y, Chen L, Wang Q, Liu S, He X
and Wang W: Deregulation of microRNA-193b affects the proliferation
of liver cancer via myeloid cell leukemia-1. Oncol Lett.
15:2781–2788. 2018.PubMed/NCBI
|
|
18
|
Wang L, Zhang Y, Zhao L, Liu S, Yu S, Ma Y
and Sun G: MicroRNA-193b inhibits the proliferation, migration and
invasion of gastric cancer cells via targeting cyclin D1. Acta
Histochem. 118:323–330. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo F, Luo Y, Mu YF, Qin SL, Qi Y, Qiu YE
and Zhong M: miR-193b directly targets STMN1 and inhibits the
malignant phenotype in colorectal cancer. Am J Cancer Res.
6:2463–2475. 2016.PubMed/NCBI
|
|
20
|
Zhong Q, Wang T, Lu P, Zhang R, Zou J and
Yuan S: miR-193b promotes cell proliferation by targeting Smad3 in
human glioma. J Neurosci Res. 92:619–626. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chambless LB, Kistka HM, Parker SL,
Hassam-Malani L, McGirt MJ and Thompson RC: The relative value of
postoperative versus preoperative Karnofsky Performance Scale
scores as a predictor of survival after surgical resection of
glioblastoma multiforme. J Neurooncol. 121:359–364. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fan Z, Cui H, Xu X, Lin Z, Zhang X, Kang
L, Han B, Meng J, Yan Z, Yan X and Jiao S: MiR-125a suppresses
tumor growth, invasion and metastasis in cervical cancer by
targeting STAT3. Oncotarget. 6:25266–25280. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dassow H and Aigner A: MicroRNAs (miRNAs)
in colorectal cancer: From aberrant expression towards therapy.
Curr Pharm Des. 19:1242–1252. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bertoli G, Cava C and Castiglioni I:
MicroRNAs: New biomarkers for diagnosis, prognosis, therapy
prediction and therapeutic tools for breast cancer. Theranostics.
5:1122–1143. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo SJ, Zeng HX, Huang P, Wang S, Xie CH
and Li SJ: MiR-508-3p inhibits cell invasion and
epithelial-mesenchymal transition by targeting ZEB1 in
triple-negative breast cancer. Eur Rev Med Pharmacol Sci.
22:6379–6385. 2018.PubMed/NCBI
|
|
29
|
Long HD, Ma YS, Yang HQ, Xue SB, Liu JB,
Yu F, Lv ZW, Li JY, Xie RT, Chang ZY, et al: Reduced hsa-miR-124-3p
levels are associated with the poor survival of patients with
hepatocellular carcinoma. Mol Biol Rep. 45:2615–2623. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao C, Wang XB, Zhang YH, Zhou YM, Yin Q
and Yao WC: MicroRNA-424 inhibits cell migration, invasion and
epithelial-mesenchymal transition in human glioma by targeting
KIF23 and functions as a novel prognostic predictor. Eur Rev Med
Pharmacol Sci. 22:6369–6378. 2018.PubMed/NCBI
|
|
31
|
Gu X, Gong H, Shen L and Gu Q:
MicroRNA-129-5p inhibits human glioma cell proliferation and
induces cell cycle arrest by directly targeting DNMT3A. Am J Transl
Res. 10:2834–2847. 2018.PubMed/NCBI
|
|
32
|
Li Z, Qian R, Zhang J and Shi X:
MiR-218-5p targets LHFPL3 to regulate proliferation, migration and
epithelial-mesenchymal transitions of human glioma cells. Biosci
Rep. 39(pii): BSR201808792019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu J, He J, Huang H, Peng R and Xi J:
MicroRNA-423-3p promotes glioma growth by targeting PANX2. Oncol
Lett. 16:179–188. 2018.PubMed/NCBI
|
|
34
|
Jiang Y, Wang X, Zhang J and Lai R:
MicroRNA-599 suppresses glioma progression by targeting RAB27B.
Oncol Lett. 16:1243–1252. 2018.PubMed/NCBI
|
|
35
|
Chan CM, Lai KKY, Ng EKO, Kiang MN, Kwok
TWH, Wang HK, Chan KW, Law TT, Tong DK, Chan KT, et al: Serum
microRNA-193b as a promising biomarker for prediction of
chemoradiation sensitivity in esophageal squamous cell carcinoma
patients. Oncol Lett. 15:3273–3280. 2018.PubMed/NCBI
|
|
36
|
Wu K, Zhao Z, Ma J, Chen J, Peng J, Yang S
and He Y: Deregulation of miR-193b affects the growth of colon
cancer cells via transforming growth factor β and regulation of the
SMAD3 pathway. Oncol Lett. 13:2557–2562. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu X and Lu J: The significance of
detection of serum miR-423-5p and miR-484 for diagnosis of
colorectal cancer. Clin Lab. 61:187–190. 2015. View Article : Google Scholar : PubMed/NCBI
|
